SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-095223
Filing Date
2023-04-07
Accepted
2023-04-07 16:09:58
Documents
6

Document Format Files

Seq Description Document Type Size
1 DEFA14A d466757ddefa14a.htm DEFA14A 31290
2 GRAPHIC g466757dsp2.jpg GRAPHIC 26661
3 GRAPHIC g466757dsp2a.jpg GRAPHIC 19279
4 GRAPHIC g466757dsp2b.jpg GRAPHIC 2030
5 GRAPHIC g466757dsp2c.jpg GRAPHIC 2670
6 GRAPHIC g466757dsp3.jpg GRAPHIC 838
  Complete submission text file 0001193125-23-095223.txt   103895
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39083 | Film No.: 23808864
SIC: 2836 Biological Products, (No Diagnostic Substances)